 Bristol-Meyers Squibb Co NYSE:BMY is up 6.4 at 74.62 at last glance and earlier traded as high as 75.99, after the U.S. Food and Drug Administration FDA approved Sotyktu, the companys oral treatment for plaque psoriasis. 